FIELD: biotechnology.
SUBSTANCE: polypeptide is a N-terminal domain for attachment to the cell wall of the S-layer protein lvis_2083 of the Lactobacillus brevis ATCC 367 bacterial strain.
EFFECT: expanded arsenal of proteins suitable for use as a component of the system for fusion proteins exposure on the lactic acid bacteria cells surface.
3 dwg, 7 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR SECRETORY PROTEIN PRODUCTION | 2002 |
|
RU2264463C2 |
| METHOD OF OBTAINING BIOLOGICALLY ACTIVE RECOMBINANT PROTEINS | 2022 |
|
RU2807615C2 |
| METHOD OF PRODUCING OF RECOMBINANT PROTEIN SAV-RGD | 2014 |
|
RU2577138C1 |
| PROTEIN OBTAINED FROM NEISSERIA MENINGITIDIS SHOWING ANTIGEN PROPERTY, ANTIBODY, NUCLEIC ACID FRAGMENT (VARIANTS) AND COMPOSITION CONTAINING THEREOF | 1999 |
|
RU2233331C2 |
| METHOD TO PRODUCE PROTEIN E7-HSP70 AND YEAST STRAIN Saccharomyces cerevisiae FOR ITS REALISATION | 2012 |
|
RU2489481C1 |
| HYBRID PROTEIN BASED ON L-ASPARAGINASE Wolinella succinogenes, STRAIN Escherichia coli - PRODUCER OF HYBRID PROTEIN (VERSIONS) AND METHOD OF PRODUCING OF HYBRID PROTEIN WITH ANTICANCER ACTIVITY | 2014 |
|
RU2562166C1 |
| APPLICATION OF FUSED POLYPEPTIDE CONTAINING MeCP2 PROTEIN AND PROTEIN TRANSDUCTION DOMAIN, PHARMACEUTICAL COMPOSITION CONTAINING SUCH PROTEIN AND METHOD OF TREATING AND/OR PREVENTING DEVELOPMENTARY NEUROPATHY | 2006 |
|
RU2432359C2 |
| STRAIN OF YEAST SACCHAROMYCES CEREVISIAE VKM CR-349D AS PRODUCER OF HUMAN EPIDERMAL GROWTH FACTOR | 1999 |
|
RU2150501C1 |
| PROTEIN CORRESPONDING TO NEISSERIA MENINGITIDIS ANTIGEN PROTEIN AND ELICITING IMMUNOGENIC PROPERTIES (VARIANTS), ANTIBODY BINDING WITH IT, NUCLEOTIDE SEQUENCE (VARIANTS) AND PHARMACEUTICAL COMPOSITION COMPRISING THEREOF | 1998 |
|
RU2232191C2 |
| ANTIGENES NEISSERIA MENINGITIDIS | 1999 |
|
RU2343159C2 |
